Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Bone Marrow Transplantation|August 26, 1998
The placental blood program of the Barcelona Cord Blood BankS Querol, M Gabarró, L Amat, et al.Carcinogenesis|August 2, 2002
The clastogenic response of the 1q12 heterochromatic region to DNA cross-linking agents is independent of the Fanconi anaemia pathwayE Callén, M J Ramírez, A Creus, et al.Bone Marrow Transplantation|March 1, 1995
G-CSF after autologous bone marrow transplantation for malignant diseases in children. Spanish Working Party for Bone Marrow Transplantation in ChildrenL Madero, A Muõnz, A Diaz de Heredia, et al.Sangre|April 1, 1996
[Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)]I Badell, J J Ortega, A Muñoz, et al.Bone Marrow Transplantation|January 7, 1999
Autologous bone marrow transplantation with monoclonal antibody purged marrow for children with acute lymphoblastic leukemia in second remission. Spanish Working Party for BMT in ChildrenM S Maldonado, C Díaz-Heredia, I Badell, et al.Bone Marrow Transplantation|September 22, 1999
Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complementA Grañena, X Castellsagué, I Badell, et al.Anales De Pediatria (Barcelona, Spain : 2003)|May 27, 2014
[Survival analysis of hematopoietic stem cell transplantation in children with primary immunodeficiency in Spain]R Hladun, I Badell, M González, et al.Journal of Hematotherapy|June 1, 1997
Immunomagnetic bone marrow purging in children with acute lymphoblastic leukemiaC Canals, C Torrico, M Picón, et al.Haematologica|January 4, 1998
Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphomaJ F Nomdedéu, I Lete, M Baiget, et al.The Pharmacogenomics Journal|July 13, 2011
Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemiaJ Salazar, A Altés, E del Río, et al.Pageof 5